Blood-Borne Cancer Cells – Quo Vadis?

Autor: Brandt, B., Schmitt, H., Feldner, J.C., Lellé, R.J., Semjonow, A., Beckmann, A.
Zdroj: International Journal of Biological Markers; January 2000, Vol. 15 Issue: 1 p111-113, 3p
Abstrakt: The detection of blood-borne cancer cells may help in clinical staging and further understanding of cancer metastasis. We developed a cytokeratin-based immunomagnetic method to isolate epithelium-derived cells from the circulating blood of patients. The number of cell clusters positive for cytokeratin/prostate-specific antigen (PSA) from the peripheral blood of prostate cancer patients and cytokeratin/p185c-erbB-2from the peripheral blood of breast cancer patients has been related to stage of the disease. Breast cancer patients who presented cytokeratin/p185c-erbB-2-positive cell clusters showed a decrease in such cells under adriamycin adjuvant therapy with Further molecular characterization by a highly sensitive microsatellite multiplex-PCR enabled reproducible detection of microsatellite alterations. The impact of these individually targeted results may contribute to an individual diagnostic and therapeutic strategy.
Databáze: Supplemental Index